Imchem Pharma
Imchem Pharma, headquartered in France, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and intermediates. Founded in 2001, the company has established a strong presence in Europe and beyond, focusing on innovative solutions for the pharmaceutical sector. With a commitment to excellence, Imchem Pharma offers a diverse range of products and services, including custom synthesis and contract manufacturing. Their unique approach combines advanced technology with stringent quality control, ensuring that clients receive reliable and effective solutions. Recognised for their expertise, Imchem Pharma has achieved significant milestones, positioning itself as a trusted partner in the global pharmaceutical market.
DitchCarbon Score
How does Imchem Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Imchem Pharma's score of 16 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Imchem Pharma's reported carbon emissions
Imchem Pharma, headquartered in France, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that Imchem Pharma may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly focuses on sustainability and carbon footprint reduction, it will be essential for Imchem Pharma to establish clear commitments and measurable targets to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Imchem Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
